BTA 0.00% 57.0¢ biota holdings limited

proposed new ceo is, page-44

  1. 8,877 Posts.
    lightbulb Created with Sketch. 20
    Take your pick Leo


    "Mr Plumb is understood to be highly regarded in US drug development circles, having enticed Bristol-Myers Squibb to sideline its original $US550m offer for Inhibitex's experimental hepatitis C drug and bid for the entire company at a significant premium to its stock price at the time."

    http://www.theaustralian.com.au/business/companies/biotas-new-chief-needed-before-merger-with-nabi-biopharmaceuticals/story-fn91v9q3-1226467655752
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.